Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Sientra Inc    SIEN

SIENTRA INC (SIEN)
Mes dernières consult.
Most popular
  Report  
Real-time Quote. Real-time Cboe BZX - 06/21 04:10:09 pm
19.835 USD   -0.58%
06/04Sientra to Present at the William Blair 38th Annual Growth Stock ..
GL
05/09SIENTRA : 1Q Earnings Snapshot
AQ
05/09Sientra Reports First Quarter 2018 Financial Results
GL
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE ETE Zonebourse : Jusqu'à 6 mois offerts sur tous les portefeuilles
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
06/15/2018 06/18/2018 06/19/2018 06/20/2018 06/21/2018 Date
20.93(c) 20.2(c) 19.63(c) 19.95(c) 19.92 Last
545 713 290 199 292 362 464 102 16 275 Volume
+0.63% -3.49% -2.82% +1.63% -0.15% Change
More quotes
Financials (USD)
Sales 2018 65,9 M
EBIT 2018 -64,0 M
Net income 2018 -66,2 M
Debt 2018 -
Yield 2018 -
Sales 2019 97,5 M
EBIT 2019 -48,5 M
Net income 2019 -50,9 M
Debt 2019 -
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
Capi. / Sales2018 8,39x
Capi. / Sales2019 5,67x
Capitalization 553 M
More Financials
Company
Sientra, Inc. operates as a medical aesthetics company, which engages in developing and commercializing plastic surgery implantable devices.Its products include breast implants, breast tissue expanders, silicone scar treatment, and additional tissue expanders.The company was founded by Hani M.... 
More about the company
Surperformance© ratings of Sientra Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on SIENTRA INC
06/07SIENTRA, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
AQ
06/04Sientra to Present at the William Blair 38th Annual Growth Stock Conference
GL
05/23CONFIRMING THE SAFETY OF SILICONE BR : NYC Plastic Surgeon Kaveh Alizadeh Co-Aut..
AQ
05/09SIENTRA : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULT..
AQ
05/09SIENTRA : 1Q Earnings Snapshot
AQ
05/09SIENTRA, INC. : Results of Operations and Financial Condition, Financial Stateme..
AQ
05/09Sientra Reports First Quarter 2018 Financial Results
GL
05/08SIENTRA : Announces Closing of $115 Million Public Offering of Common Stock and ..
AQ
05/07Sientra, Inc. Announces Closing of $115 Million Public Offering of Common Sto..
GL
05/04Sientra® to Release First Quarter 2018 Financial Results on Wednesday, May 9,..
GL
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
06/15Essilor Calls General Meeting for EssilorLuxottica
DJ
06/14STRYKER : Says It Isn't in Deal Talks -- WSJ
DJ
06/13STRYKER : Says It Isn't in Deal Talks With Boston Scientific -- Update
DJ
06/13STRYKER : Says It's Not in Deal Talks with Boston Scientific
DJ
06/12STRYKER : Approaches Rival Boston Scientific for Deal -- WSJ
DJ
More sector news : Medical Equipment, Supplies & Distribution - NEC
Latest Tweets
06/20Sientra $SIEN Receives Consensus Recommendation of “Buy” from Brokerages  
06/16Sientra $SIEN Hits New 52-Week High and Low at $21.06  
06/15Sientra $SIEN Hits New 1-Year High and Low at $21.06  
06/15: wing Patrick Williams remains patient with the process as & powers p..
1
06/11Head-To-Head Analysis: Sientra $SIEN versus Intuitive Surgical $ISRG  
More tweets
Qtime:155
News from SeekingAlpha
05/27WEEK 22 BREAKOUT FORECAST : Short-Term Picks To Give You An Edge 
05/20WEEK 21 BREAKOUT FORECAST : Short-Term Picks To Give You An Edge 
05/14WEEK 20 BREAKOUT FORECAST : Short-Term Picks To Give You An Edge 
05/11Daily Insider Ratings Round Up 5/9/18 
05/10Sientra's (SIEN) CEO Jeffrey Nugent on Q1 2018 Results - Earnings Call Transc.. 
Chart SIENTRA INC
Duration : Period :
Sientra Inc Technical Analysis Chart | SIEN | US82621J1051 | 4-Traders
Technical analysis trends SIENTRA INC
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Average target price 21,3 $
Spread / Average Target 6,9%
EPS Revisions
Managers
NameTitle
Jeffrey M. Nugent Chairman & Chief Executive Officer
Charles Huiner COO, SVP-Corporate Development & Strategy
Patrick F. Williams CFO, Treasurer & Principal Accounting Officer
Rosalyn Cole d’Incelli VP-Clinical Operations & Medical Affairs
Nicholas Simon Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
SIENTRA INC41.89%553
MEDTRONIC PLC7.26%117 389
BAXTER INTERNATIONAL14.74%39 889
ALIGN TECHNOLOGY64.38%29 274
TERUMO CORP27.51%23 535
ZIMMER BIOMET HOLDINGS-7.11%22 728